# Implantation or Injectable Dosage Form New Animal Drugs; Tylosin
> **Food and Drug Administration** · Final rule. · Published 2009-03-19 · Effective 2009-03-19 · 74 FR 11643
## Document
- **Document number:** E9-6009
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 74 FR 11643
- **CFR reference:** 21 CFR 522
- **Publication date:** 2009-03-19
- **Effective date:** 2009-03-19
- **HHS docket:** Docket No. FDA-2009-N-0665
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for changing scientific nomenclature for a bovine pathogen on labeling for tylosin injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2009/03/19/E9-6009/implantation-or-injectable-dosage-form-new-animal-drugs-tylosin)
---
*AI Analytics · CC0 1.0*